Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Rose Rose who wrote (15822)	5/8/1998 9:32:00 AM
From: Don Powrie	Read Replies (2) \| Respond to of 34592

>>>> NEWS!! Nasdaq:TRGA Friday May 8, 9:00 am Eastern Time Company Press Release SOURCE: Trega Biosciences, Inc. Trega Biosciences Reaches Milestone In Procter & Gamble Deal; Trega Chemistry Used to Discover Lead Compounds SAN DIEGO, May 8 /PRNewswire/ -- Trega Biosciences, Inc. (Nasdaq: TRGA - news) today announced that it has reached a research milestone in its agreement with the Procter & Gamble Company (P&G). Using Trega's combinatorial chemistry libraries, P&G has identified a series of lead compounds that are active against a P&G biological target. As a result of this accomplishment, P&G has exercised its option to an exclusive, world-wide license to further develop these compounds. The milestone also triggered an undisclosed cash payment to Trega. ''We are happy to announce the achievement of this milestone with P&G,'' said Robert S. Whitehead, Trega's chairman and chief executive officer. ''This is the second announcement this year we have made regarding a pharmaceutical company identifying valuable lead compounds to move into development from Trega libraries. These achievements are indicative of the value of Trega's combinatorial chemistry libraries for enhancing the drug discovery efforts of our pharmaceutical partners.''